← Back to headlines
FibroBiologics, Inc. (FBLG) Advances Toward Psoriasis Treatment with CYPS317 Data
FibroBiologics, Inc. (FBLG) is reportedly making progress toward a breakthrough psoriasis treatment, supported by new data for its compound CYPS317.
2 Jun, 13:57 — 2 Jun, 13:57
Sources
Showing 1 of 1 sources
